Skip to main content
Premium Trial:

Request an Annual Quote

Abbott Lab Automation System Receives FDA Approval

NEW YORK – Abbott announced on Thursday that its new laboratory automation system has received approval from the US Food and Drug Administration and is now available in the US.

The GLP Systems Track includes a self-propelled single sample carrier, called CAR, that allows samples to move independently without a belt instead of being attached to a fixed mechanized track system. The technology reduces mechanical failures and increases flexibility for laboratories, Abbott said in a statement. The automation system is fully customizable and allows samples to travel automatically throughout the system. 

It can also handle up to 25,000 test tubes per day and help reduce operational costs and eliminate manual errors, Abbott said. 

"We know that our customers are seeking flexibility and scalability in their laboratory operations so they can meet ever-growing demand," Louis Morrone, executive VP for Abbott's core diagnostics business, said in a statement. "GLP Systems Track addresses those needs, enabling labs to increase performance and improve the overall quality of their operations."

The system is not approved for use in US blood donor and plasma testing laboratories, the Abbott Park, Illinois-based company noted.